Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biofrontera Inc. - Common Stock (NQ:BFRI)

0.8951 +0.0451 (+5.31%)
Streaming Delayed Price Updated: 10:13 AM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biofrontera Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Mid-Day Market Update: Gap Drops Following Downbeat Q3 Results; Ocuphire Pharma Shares Jump
Midway through trading Wednesday, the Dow traded down 0.28% to 35,714.19 while the NASDAQ fell 0.29% to 15,729.96. The S&P also fell, dropping 0.20% to 4,681.42. The U.S. has... 
Via Benzinga
Topics Stocks
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Biofrontera Inc. (NASDAQ: BFRI) shares jumped 109.5% to $5.51 after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target. Longeveron Inc... 
Via Benzinga
BENE Stock: 9 Things to Know About DWAC Sister SPAC Benessere Capital
Benessere Capital Acquisition (BENE) stock is on the move Wednesday after the SPAC revealed merger plans with eCombustible Energy today. 
Via InvestorPlace
PTN Stock Alert: Why One Analyst Sees 1,371% Upside for Palatin Technologies
Palatin Technologies (PTN) stock is taking off on Wednesday thanks to an incredibly bullish new analyst price target for the shares. 
Via InvestorPlace
GAME Stock: 6 Reasons Why Engine Gaming and Media Investors Are Feeling Thankful Today
Engine Gaming and Media (GAME) stock is on the move today as investors celebrate positive fiscal Q4 2021 earnings results. 
Via InvestorPlace
BFRI Stock: 7 Things to Know About Biofrontera as Shares Rocket on $20 Price Prediction
Biofrontera (BFRI) stock is catching the eyes of investors on Wednesday following a bullish price prediction and new rating. 
Via InvestorPlace
Mid-Morning Market Update: Markets Open Lower; Deere Earnings Top Views
Following the market opening Wednesday, the Dow traded down 0.30% to 35,706.59 while the NASDAQ fell 0.61% to 15,678.70. The S&P also fell, dropping 0.34% to 4,674.85. The U.S... 
Via Benzinga
Topics Stocks
Benzinga's Top Ratings Upgrades, Downgrades For November 24, 2021
Upgrades For Aegon NV (NYSE:... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Ocuphire Pharma (NASDAQ:OCUP) stock rose 78.73% to $6.22 during Wednesday's pre-market session. The market value of their outstanding shares is at $107.6... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Qualigen Therapeutics (NASDAQ:QLGN 
Via Benzinga
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers NeuroOne Medical Tech (NASDAQ:NMTC... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Biofrontera (NASDAQ:BFRA) stock r... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) stock increased by 44.96% to $20.31 during Monday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Sundial Growers (NASDAQ:SNDL) stock increased by 28.49% to $0.93 during Friday's pre-market session. The market value of their outstanding shares is at $1.9... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock increased by 16.73% to $14.86 during Tuesday's regular session. The current volume of 1.0 million shares is 269.7%... 
Via Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news.... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.